Biotech · Private company
InventisBio Co., Ltd
Track this companyFree. Adds InventisBio Co., Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials102 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- AllopurinolPhase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- D-0120Phase 2 · GoutClinicalTrials.gov · fetched Nov 12, 2026
- D-1553Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- D-1553 in combination with Drug: pembrolizumab, Drug:KEYTRUDA® , Drug: cetuximab, Drug: otherPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- D-2570 TabletPhase 2 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-D-0502Phase 1 · Mass Balance RecoveryClinicalTrials.gov · fetched Nov 12, 2026
- D-0120Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- D-0120 in combination with AllopurinolPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- D-0502Phase 1 · Healthy Female VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- D-0502Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- D-2570Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- palbociclibPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisPHASE2 · RECRUITING · started Jun 3, 2026ClinicalTrials.gov NCT07489885 · fetched Nov 12, 2026
- Healthy Volunteer StudyPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 4, 2025ClinicalTrials.gov NCT07270783 · fetched Nov 12, 2026
- Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With GoutPHASE2 · COMPLETED · started Apr 17, 2023ClinicalTrials.gov NCT05665699 · fetched Nov 12, 2026
- Study in Healthy Adult Female SubjectsPHASE1 · COMPLETED · started Mar 29, 2022ClinicalTrials.gov NCT05339633 · fetched Nov 12, 2026
- Evaluation of PK and Safety of D-0120 and AllopurinolEARLY_PHASE1 · COMPLETED · started Nov 1, 2021ClinicalTrials.gov NCT05360628 · fetched Nov 12, 2026
- Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female SubjectsPHASE1 · COMPLETED · started Oct 27, 2021ClinicalTrials.gov NCT05226338 · fetched Nov 12, 2026
- Study to Evaluate D-1553 in Subjects With Solid TumorsPHASE1_PHASE2 · UNKNOWN · started Oct 2, 2020ClinicalTrials.gov NCT04585035 · fetched Nov 12, 2026
- Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy VolunteersPHASE1 · COMPLETED · started Sep 18, 2019ClinicalTrials.gov NCT04097405 · fetched Nov 12, 2026
- Food Effect Study of D-0502 Tablet in Healthy VolunteersPHASE1 · COMPLETED · started Oct 23, 2018ClinicalTrials.gov NCT03810625 · fetched Nov 12, 2026
- A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast CancerPHASE1 · COMPLETED · started Mar 18, 2018ClinicalTrials.gov NCT03471663 · fetched Nov 12, 2026